257 related articles for article (PubMed ID: 26940105)
21. Services for people at high risk improve outcomes in patients with first episode psychosis.
Fusar-Poli P; Díaz-Caneja CM; Patel R; Valmaggia L; Byrne M; Garety P; Shetty H; Broadbent M; Stewart R; McGuire P
Acta Psychiatr Scand; 2016 Jan; 133(1):76-85. PubMed ID: 26358300
[TBL] [Abstract][Full Text] [Related]
22. Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial.
Clausen L; Hjorthøj CR; Thorup A; Jeppesen P; Petersen L; Bertelsen M; Nordentoft M
Psychol Med; 2014 Jan; 44(1):117-26. PubMed ID: 23590927
[TBL] [Abstract][Full Text] [Related]
23. [Prescription practices of antipsychotic medication in early psychosis: a two-year follow-up survey of subjects admitted in two psychiatric hospitals of South-Western France].
Grolleau A; Cougnard A; Parrot M; Kalmi E; Desage A; Misdrahi D; Brun-Rousseau H; Verdoux H
Encephale; 2007; 33(3 Pt 1):326-31. PubMed ID: 17675930
[TBL] [Abstract][Full Text] [Related]
24. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
[TBL] [Abstract][Full Text] [Related]
25. Is cannabis an anti-antipsychotic? The experience in psychiatric intensive care.
Isaac M; Isaac M; Holloway F
Hum Psychopharmacol; 2005 Apr; 20(3):207-10. PubMed ID: 15682431
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and predictors of admission at the time of presentation in first episode psychosis.
Gannon L; Mullen E; McGorry P; O'Donoghue B
Soc Psychiatry Psychiatr Epidemiol; 2024 Jul; 59(7):1143-1151. PubMed ID: 37660304
[TBL] [Abstract][Full Text] [Related]
27. Clinical Challenges in Patients with First Episode Psychosis and Cannabis Use: Mini-Review and a Case Study.
Gerlach J; Koret B; Gereš N; Matić K; Prskalo-Čule D; Zadravec Vrbanc T; Lovretić V; Skopljak K; Matoš T; Šimunović Filipčić I; Filipčić I
Psychiatr Danub; 2019 Jun; 31(Suppl 2):162-170. PubMed ID: 31158117
[TBL] [Abstract][Full Text] [Related]
28. Association Between Continued Cannabis Use and Risk of Relapse in First-Episode Psychosis: A Quasi-Experimental Investigation Within an Observational Study.
Schoeler T; Petros N; Di Forti M; Pingault JB; Klamerus E; Foglia E; Small A; Murray R; Bhattacharyya S
JAMA Psychiatry; 2016 Nov; 73(11):1173-1179. PubMed ID: 27680429
[TBL] [Abstract][Full Text] [Related]
29. Oral and long-acting injectable antipsychotic discontinuation and relationship to side effects in people with first episode psychosis: a longitudinal analysis of electronic health record data.
Patel R; Brinn A; Irving J; Chaturvedi J; Gudiseva S; Correll CU; Fusar-Poli P; McGuire P
Ther Adv Psychopharmacol; 2023; 13():20451253231211575. PubMed ID: 38107162
[TBL] [Abstract][Full Text] [Related]
30. [Atypical antipsychotics in first-episode psychosis: a review].
Rotgé JY; Aouizerate B; Tignol J
Encephale; 2008 Apr; 34(2):194-204. PubMed ID: 18597729
[TBL] [Abstract][Full Text] [Related]
31. Predictors of care home and hospital admissions and their costs for older people with Alzheimer's disease: findings from a large London case register.
Knapp M; Chua KC; Broadbent M; Chang CK; Fernandez JL; Milea D; Romeo R; Lovestone S; Spencer M; Thompson G; Stewart R; Hayes RD
BMJ Open; 2016 Nov; 6(11):e013591. PubMed ID: 27864252
[TBL] [Abstract][Full Text] [Related]
32. Social network confidants, duration of untreated psychosis and cannabis use in people with first episode psychosis: An exploratory study.
Carrà G; Battaglia C; Hinton M; Sheridan Rains L; Crocamo C; Johnson S
Early Interv Psychiatry; 2018 Oct; 12(5):942-946. PubMed ID: 28858430
[TBL] [Abstract][Full Text] [Related]
33. Effect of cannabis on weight and metabolism in first-episode non-affective psychosis: Results from a three-year longitudinal study.
Vázquez-Bourgon J; Setién-Suero E; Pilar-Cuéllar F; Romero-Jiménez R; Ortiz-García de la Foz V; Castro E; Crespo-Facorro B
J Psychopharmacol; 2019 Mar; 33(3):284-294. PubMed ID: 30702972
[TBL] [Abstract][Full Text] [Related]
34. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
Di Forti M; Quattrone D; Freeman TP; Tripoli G; Gayer-Anderson C; Quigley H; Rodriguez V; Jongsma HE; Ferraro L; La Cascia C; La Barbera D; Tarricone I; Berardi D; Szöke A; Arango C; Tortelli A; Velthorst E; Bernardo M; Del-Ben CM; Menezes PR; Selten JP; Jones PB; Kirkbride JB; Rutten BP; de Haan L; Sham PC; van Os J; Lewis CM; Lynskey M; Morgan C; Murray RM;
Lancet Psychiatry; 2019 May; 6(5):427-436. PubMed ID: 30902669
[TBL] [Abstract][Full Text] [Related]
35. Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
Psychiatry Res; 2017 Sep; 255():36-41. PubMed ID: 28521146
[TBL] [Abstract][Full Text] [Related]
36. What proportion of patients with psychosis is willing to take part in research? A mental health electronic case register analysis.
Patel R; Oduola S; Callard F; Wykes T; Broadbent M; Stewart R; Craig TK; McGuire P
BMJ Open; 2017 Mar; 7(3):e013113. PubMed ID: 28279995
[TBL] [Abstract][Full Text] [Related]
37. Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.
Haring L; Koido K; Vasar V; Leping V; Zilmer K; Zilmer M; Vasar E
Schizophr Res; 2015 Dec; 169(1-3):22-29. PubMed ID: 26364730
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
[TBL] [Abstract][Full Text] [Related]
39. Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care.
Fusar-Poli P; De Micheli A; Signorini L; Baldwin H; Salazar de Pablo G; McGuire P
EClinicalMedicine; 2020 Nov; 28():100578. PubMed ID: 33294806
[TBL] [Abstract][Full Text] [Related]
40. Predictors of hospitalisation and recovery following full antipsychotic discontinuation in first episode psychosis. A naturalistic retrospective cohort study.
Wilson M; Harris M; Pereira M; Buckle J; Forshall E; Murphy T; Thompson A; Kavanagh G; Whale R
Schizophr Res; 2023 Nov; 261():269-274. PubMed ID: 37862826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
